Fight Brewing In Congress Over Part D Coverage Gap Discounts
You may also be interested in...
The Best Choice: HHS Lead On Drug Price Reform Brings Expertise In Part D Contracting
Appointment of CVS Health executive Daniel Best could help Centers for Medicare and Medicaid Services address some pharmacy benefit manager concerns with point-of-sale rebates in Part D.
No Deal: Omnibus Spending Bill Moves Without Part D Discount Relief
Biopharma lobbying to include provision to reduce the 70% discount on brands in the budget bill runs out of time, leaving industry evaluating other possible legislative vehicles.
The Ups and Downs Of US Drug Pricing Policy
If 2017 was the year of talk (tweets) on prescription drug pricing policy, 2018 is shaping up to be the year of action.